12 Recruiting Trials

Clinical Trials
for Parkinson's in Alabama

12 clinical trials for Parkinson's are currently recruiting participants at study sites in Alabama. Study-related care is provided at no cost.

12
Recruiting trials
7
Study sites
2
Cities
3
Industry-sponsored
3
Phase 2
3
Phase 3

Parkinson's clinical trials in Alabama: what to expect

Parkinson's trials fall into three groups. Disease-modifying studies test drugs meant to slow progression, including treatments aimed at alpha-synuclein, repurposed diabetes drugs and therapies for people with LRRK2 or GBA gene variants. Symptom studies test new ways to smooth out "off" periods and dyskinesia, and procedures such as focused ultrasound and deep brain stimulation. And a large number of studies involve no medicine: exercise, speech and balance programs, wearables, and long-term observational studies that track the disease.

In Alabama, recruiting parkinson's studies are concentrated in Birmingham and Mobile. 3 of the 12 are run by a drug or device company, which usually means a larger study with travel reimbursement; the rest are academic or hospital-led.

Who Parkinson's trials usually look for

Disease-modifying trials usually enroll people diagnosed in the last two to five years, sometimes before any Parkinson's medicine has started. Symptom trials want people on levodopa who have a stated number of hours of "off" time a day. Most set ages 30 to 80, exclude dementia and atypical parkinsonism, and may require a dopamine transporter scan to confirm the diagnosis. Genetic trials test for the variant at no cost. Exercise and observational studies accept a much wider range.

What taking part involves

Screening includes a movement exam, sometimes performed both before and after your morning dose, blood work and a scan. Drug trials run twelve weeks to two years with monthly visits, symptom diaries and, in some, a spinal fluid test. Placebo arms are common and medicines you already take generally continue. Exercise and rehabilitation trials involve sessions two or three times a week for several months. Everything study-related is free and travel is usually reimbursed; a care partner is welcome and sometimes required.

Questions worth asking the study team

Whether you must skip a dose before visits; whether your current medicines continue; what the chance of placebo is and whether an extension follows; how many visits are required; and whether you will be told the results of any scans or genetic tests.

Showing 12 of 12 recruiting Parkinson's trials in Alabama

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
PHASE3 Birmingham, Alabama +4 sites NCT07174310
This trial is looking for people with early-stage Parkinson's disease who are currently on stable treatment with levodopa. Participants will receive either the drug prasinezumab or a placebo to study its effects.
Recruiting
Parkinson's Foundation PD GENEration Genetic Registry
N/A Birmingham, Alabama +4 sites NCT04994015
This trial is looking for people with Parkinson's disease who are willing to undergo genetic testing. Participants will help build a genetic database for future research on the condition.
Recruiting
A Study of Buntanetap in Participants With PD
PHASE2 Birmingham, Alabama +4 sites NCT07284784
This trial is looking for adults with Parkinson's Disease who are either already on deep brain stimulation treatment or have participated in earlier trials with buntanetap. Participants will take the medication for 36 months and attend regular check-ups.
Recruiting
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
PHASE2 Birmingham, Alabama +4 sites NCT06976268
This trial is looking for adults aged 40 to 80 with early Parkinson's disease. Participants will receive treatment over 48 weeks, followed by another 48 weeks of open access to the treatment.
Recruiting
The University of Alabama at Birmingham (UAB) Neuroinflammation in Parkinson's Disease-TSPO- Positron Emission Tomography (PET) Substudy
PHASE1 Birmingham, Alabama NCT03457493
This trial is looking for people with Parkinson's disease to measure brain inflammation. Participants will undergo a PET imaging scan to study how the brain's immune cells are activated and compare their results with healthy individuals.
Recruiting
Low Voltage Electrical Stimulation for Depression in Parkinson's Patients
NA Mobile, Alabama NCT06467695
This trial is looking for adults with Parkinson's disease who experience depression. Participants will receive a specific type of electrical stimulation to see if it can improve their mood and brain activity.
Recruiting
Investigating Inhibitory Control Networks in Parkinson's Disease
NA Birmingham, Alabama NCT04735458
This trial is looking for people with Parkinson's disease or essential tremor who are getting ready for surgery. Participants will help researchers learn more about brain activity related to non-motor symptoms during surgery.
Recruiting
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
N/A Birmingham, Alabama +4 sites NCT04477785
This trial is looking for people with Parkinson's disease, healthy volunteers, or those at risk of Parkinson's. Participants will help researchers understand how the disease progresses and identify markers for future treatments.
Recruiting
Black and African Americans Connections to Parkinson's Disease (BLAAC PD)
N/A Birmingham, Alabama +4 sites NCT06719583
This trial is looking for Black and African American individuals to help understand Parkinson's disease. Participants will share their experiences and may provide saliva samples for research.
Recruiting
Sensory Filtering in the Human Basal Ganglia as a Mechanism of Parkinson's Disease
N/A Birmingham, Alabama NCT05482126
This trial is looking for adults with advanced Parkinson's disease and healthy individuals without neurological conditions. Participants will help researchers understand brain activity related to movement disorders and may undergo deep brain stimulation surgery.
Recruiting
Stimulus-Evoked Directional Field Potentials to Guide Subthalamic and Pallidal DBS for PD
NA Birmingham, Alabama NCT06169852
This trial is looking for people with advanced Parkinson's disease who are considering surgery to help manage their symptoms. Participants will undergo a specific type of brain surgery to improve their condition and help researchers learn more about the effects of this treatment.
Recruiting
Longitudinal TSPO PET Imaging With [18F]DPA-714 in PPMI (PPMI DPA-714 PET Imaging)
EARLY_PHASE1 Birmingham, Alabama NCT06289582
This trial is looking for people with early Parkinson's Disease or healthy volunteers. Participants will receive an injection of a PET imaging agent and undergo monitoring over 24 months to assess brain activity related to the disease.
Recruiting

Where the Parkinson's studies are in Alabama

  • University of Alabama at Birmingham, Birmingham6 trials
  • Site-049, Birmingham1 trial
  • The University of Alabama at Birmingham Hospital, Birmingham1 trial
  • UAB, Birmingham1 trial
  • UAB Advanced Imaging Facility, Birmingham1 trial
  • University of Alabama Birmingham, Birmingham1 trial

Counts are recruiting studies listing at least one site in Alabama, from ClinicalTrials.gov, refreshed every two days.

Parkinson's clinical trials in Alabama: common questions

How many Parkinson's clinical trials are recruiting in Alabama?
TrialFinder currently lists 12 recruiting Parkinson's clinical trials with study sites in Alabama. Results are updated regularly from ClinicalTrials.gov, the official U.S. registry of clinical studies.
Where are Parkinson's clinical trials located in Alabama?
Study sites for the Parkinson's trials listed on this page include Birmingham, Mobile. Each trial page lists every participating site with contact details, so you can find the location closest to you.
Do I need insurance to join a Parkinson's clinical trial in Alabama?
No. Study-related care is covered by the trial sponsor at no cost to participants, including the study treatment, required lab tests and study visits. Many Parkinson's trials in Alabama also compensate participants for time and travel. Health insurance is not required to search or enroll.
How do I qualify for a Parkinson's clinical trial in Alabama?
Each study sets its own criteria based on age, Parkinson's diagnosis details, prior treatments, current medications and general health. The fastest way to find out is to contact a research site directly — most will pre-screen you by phone in 10 to 15 minutes at no charge. You can also create a free TrialFinder profile to be matched automatically.
Can I join a Parkinson's trial if I take carbidopa-levodopa?
Yes for most trials, including every study of "off" time. Some disease-modifying trials want people who have not started medicine yet; the listing says so.
What does "off time" mean in a trial listing?
The hours each day when your medicine has worn off and symptoms return. Trials of new symptom treatments usually require about two or more hours of off time a day, recorded in a diary during screening.
Are there Parkinson's trials that do not involve medicine?
Many. Exercise, speech, balance and dance programs, wearable sensors, deep brain stimulation settings and observational studies all recruit, and most accept people at any stage who can attend sessions.
Are Clinical Trials Safe? What Patients Should Know
How clinical trial safety works — phases, IRB oversight, informed consent, and your right to withdraw — plus the real risks and questions to ask.
How to Know If You Qualify for a Clinical Trial
Every trial has eligibility criteria based on diagnosis, age, and medical history. Here's how to tell if you qualify — and what to do if you're not sure.
Clinical Trials Without Insurance: What You Need to Know
Clinical trials cover the cost of study-related care, making them one of the few ways to access treatment without health insurance. Here's what's covered.
All guides →

Check Your Eligibility

Create a free profile and our AI will match you to Parkinson's trials near you in Alabama.

Get Matched — Free
No insurance required

Parkinson's disease trials test dopamine-replacement therapies, deep brain stimulation, gene therapies, and neuroprotective compounds to slow disease progression.

All Parkinson's trials →